• Fasudil and Hippo Signaling: A Translational ROCK Strategy

  2026-09-11

  Fasudil (HA-1077) HCl is more than a catalog ROCK inhibitor: it is a practical perturbation tool for separating cytoskeletal signaling, proliferation, migration, and apoptosis. By placing Fasudil alongside the 2025 quercetin–Hippo cataract study, this article defines a disciplined path from pathway observation to translational experiment without overstating cross-domain evidence.

• Separating Caspase-6 Apoptosis from Pyroptosis

  2026-09-11

  A translational framework for using Z-VEID-FMK to distinguish caspase-6-dependent apoptosis from caspase-1-driven pyroptosis in neuronal and cancer models, informed by recent HOXC8 research in NSCLC.

• Quercetin, Hippo Signaling, and Cataract Protection

  2026-09-10

  A 2025 study integrates network pharmacology, a UVB-induced cataract mouse model, and hydrogen peroxide-injured lens epithelial cells to investigate how quercetin protects the lens. Its findings link reduced oxidative stress and improved epithelial-cell survival to suppression of Hippo pathway activity, while pharmacologic pathway reactivation weakened these effects.

• HEY2, Mitochondrial Respiration, and Cardiac Homeostasis

  2026-09-10

  The reference study identifies HEY2 as an inducible transcriptional brake on mitochondrial oxidative metabolism in cardiomyocytes. By combining disease-associated human samples with zebrafish, mouse, and cell-based perturbation models, it connects HEY2–HDAC1 repression of Ppargc1 and Cpt-related programs to reactive oxygen species, cardiomyocyte loss, and heart failure, while showing that targeted restoration of metabolic regulators can improve bioenergetic defects.

• Influenza Hemagglutinin (HA) Peptide Workflow Guide

  2026-09-09

  Use the Influenza Hemagglutinin (HA) Peptide to release HA-tagged proteins from antibody capture systems under comparatively mild, tunable conditions. This practical guide covers immunoprecipitation, interaction studies, exosome-related assays, optimization, and troubleshooting.

• BRCAness and Olaparib Sensitivity in Mesothelioma

  2026-09-09

  Borchert et al. connected homologous recombination repair gene-expression patterns with olaparib response in malignant pleural mesothelioma models. The study highlights BAP1-associated BRCAness as a potential basis for treatment stratification while identifying AURKA, RAD50, and DDB2 as prognostic candidates.

• Small-Molecule Pancreatic Ductal Organoids

  2026-09-08

  The reference study presents a small-molecule cocktail strategy for improving the initiation, ductal enrichment, and long-term expansion of pancreatic ductal organoids. Its findings support a reproducible exocrine model that retains ductal and acinar heterogeneity and may be useful for pancreatic disease research and drug screening.

• Morin, AMPD2, and Podocyte Energy Metabolism

  2026-09-07

  A 2025 study identifies excessive AMPD activity in the purine nucleotide cycle as a mechanistic link between fructose exposure, podocyte mitochondrial dysfunction, and glomerular injury. Using rat and MPC5 podocyte models, the authors show that Morin suppresses this metabolic disturbance and position AMPD2 as a potential target for further kidney research.

• HA Tag Peptide as a Translational Mechanism Tool

  2026-09-07

  Translational researchers need more than pathway diagrams: they need reproducible ways to capture, release, and verify protein complexes. This article examines how the Influenza Hemagglutinin (HA) Peptide can support mechanistic studies of NEDD4L-mediated PRMT5 regulation while clarifying what the colorectal cancer evidence does—and does not—establish.

• Engineering a Simpler Bitespiramycin Producer

  2026-09-05

  The reference study used an in-frame partial deletion of the sspA 3-O-acyltransferase gene to redirect Streptomyces spiramyceticus WSJ-1 toward production of 400-isovalerylspiramycin I with reduced component complexity. Its main contribution is a targeted biosynthetic-engineering strategy that separates pathway control from downstream susceptibility testing and offers a framework for improving antibiotic product consistency.

• Y-27632 Dihydrochloride in Microfabricated Assays

  2026-09-05

  Y-27632 dihydrochloride is a selective ROCK inhibitor for dissecting how cytoskeletal signaling interacts with engineered cell environments. This guide presents a practical framework for combining pharmacological perturbation with rapid, microscope-enabled microfabrication while separating geometry effects from ROCK-dependent biology.

• CRTC-CREB Sensing of Proteotoxic Stress in Drosophila

  2026-09-04

  The reference study identifies CRTC-CREB as a stress-responsive transcriptional system that links proteasome inhibition to ROS and JNK signaling in Drosophila. Its experiments suggest that enhancing this pathway can improve proteostasis and reduce Huntington’s disease-associated protein aggregation, while also defining important limits for translation to mammalian and oncology models.

• T7 RNA Polymerase for Reliable RNA Workflows

  2026-09-04

  This scenario-driven guide explains how T7 RNA Polymerase, SKU K1083, can standardize upstream RNA production for cell viability, proliferation, and cytotoxicity studies. It covers promoter-specific template design, protocol controls, interpretation of biological effects, and practical vendor-selection criteria.

• Sisomicin Activity Versus Tobramycin and Gentamicin

  2026-09-03

  This 1974 study benchmarked sisomicin against five aminoglycosides using 565 clinical isolates, showing broad in vitro activity against Gram-negative bacilli and selected Gram-positive cocci. Its comparative MIC design also identified cross-resistance between sisomicin, gentamicin, and Tobramycin, while highlighting amikacin as a potentially useful option for resistant isolates.

• Acetylcysteine in Redox-Immune Assays

  2026-09-02

  Learn how Acetylcysteine and N-acetyl-L-cysteine can function as mechanistic redox controls in photothermal and immune-remodeling assays, with practical guidance for separating oxidative injury from heat-driven and immune-mediated effects.

8718 records 1/582 page Next 12345 下5页 Last page